Concepedia

Masafumi Katou

MK

Statistics

Publications

3

Citations

56

H-Index

3

Active since

2014

Affiliations

Takeda (Japan)(Current)

Kawasaki Medical School

Masafumi Katou is an author at Takeda (Japan) specializing in diabetes pharmacotherapy, clinical pharmacology, and pharmacovigilance.

Publications per year

2014–2016

3

Publications

3

Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase

Kohei Kaku, Mikiko Mori, Tatsuhiro Kanoo et al. · Expert Opinion on Pharmacotherapy · 2014 · 31 citations

, , +15

Randomized, double‐blind, phase <scp>III</scp> study to evaluate the efficacy and safety of once‐daily treatment with alogliptin and metformin hydrochloride in Japanese patients with type 2 diabetes

Kohei Kaku, Shuuji Sumino, Masafumi Katou et al. · Diabetes Obesity and Metabolism · 2016 · 13 citations · Full text

, , +14

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double‐blind, parallel‐group, comparative study

Kohei Kaku, Masafumi Katou, Masataka Igeta et al. · Diabetes Obesity and Metabolism · 2015 · 12 citations

, , +17

1–3 of 3